e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Gas exchange and paediatric exercise testing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation
P. Latzin, R. Kraemer (Berne, Switzerland)
Source:
Annual Congress 2010 - Gas exchange and paediatric exercise testing
Session:
Gas exchange and paediatric exercise testing
Session type:
Thematic Poster Session
Number:
896
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Latzin, R. Kraemer (Berne, Switzerland). Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation. Eur Respir J 2010; 36: Suppl. 54, 896
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients
Related content which might interest you:
Stenotrophomonas maltophilia
and
achromobacter xylosoxidans
in cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Cystic fibrosis patients: do they profit from altitiude residence?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
Cystic fibrosis: Heartburn and lung function – ²Too hot to handle²
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Long term non invasive positive pressure ventilation is associated with a stabilisation in the decline of lung function in patients with cystic fibrosis
Source: Annual Congress 2006 - Interventions and outcome in chronic respiratory failure - new aspects and deeper insights
Year: 2006
Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis?
Source: Eur Respir J 2006; 28: 96-101
Year: 2006
Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Identifying pulmonary hypertension in patients with interstitial lung disease – Evaluating an unmet need
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Changes in ventilatory mechanics with increasing disease severity in children and adolesecents with cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002
Daily tele-monitoring of symptoms and spirometry in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) – A comparative study
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Airway-centered interstitial fibrosis – Two case reports
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 685s
Year: 2005
Impact of sensitization to
Aspergillus fumigatus
on lung function in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis
Source: Eur Respir J 2001; 17: 712-715
Year: 2001
Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept